Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 15 (MTND2P15) is a classified pseudogene, meaning it is a non-functional DNA sequence derived from the MT-ND2 gene, a mitochondrial gene encoding a subunit of respiratory chain Complex I[4]. While the MT-ND2 gene is essential for mitochondrial electron transport, MTND2P15 has lost protein-coding capability and is not known to be translated into a functional product. There are no established physiological, therapeutic, or diagnostic roles for this pseudogene. Current literature has not identified disease associations or any evidence of MTND2P15 acting as a functional biomolecule or drug target. Some paralogous mitochondrial pseudogenes may show tissue-specific expression differences in certain diseases (such as neurodegenerative disease), but MTND2P15 itself is not specifically described as relevant in these contexts and is not actively considered in therapeutic targeting[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 15 (MTND2P15).